Keywords: gw, naramig, cleared, european, markets, glaxo, wellcome

GW's Naramig Cleared In 10 European Markets

Article | 24 July 1997

- Glaxo Wellcome's new antimigraine drug Naramig (naratriptan) has beencleared in 10 additional European markets under the mutual recognition procedure. This follows ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Amerge

Naratriptan

Go to drug listing